Published in MD Week, May 4th, 2007
Among these are several studies with PEGINTRON(R) (peginterferon alfa-2b) and REBETOL(R) (ribavirin) combination therapy, a current standard of care in the treatment of chronic hepatitis C, evaluating how results at important treatment milestones can help...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of MD Week